Skip to main content

and
  1. Article

    Open Access

    Bevacizumab combined with gemcitabine and capecitabine for advanced pancreatic cancer: a phase II study

    A total of 50 patients with advanced pancreatic cancer were enrolled in a phase II study of bevacizumab 15 mg kg−1, capecitabine 1300 mg m−2 daily for 2 weeks and gemcitabine 1000 mg m−2 weekly 2 times; cycles we...

    M Javle, J Yu, C Garrett, A Pande, B Kuvshinoff, A Litwin in British Journal of Cancer (2009)

  2. No Access

    Article

    Radical reresection is indicated for all T2 and T3 gallbladder cancers and results in the same survival as primarily resected gallbladder cancers

    H. Hoshi, J. M. Foster, Q. Chu, B. Kuvshinoff, A. Rajput in Annals of Surgical Oncology (2004)

  3. No Access

    Article

    Radical reresction in indicated for all T2 and T3 gallbladder and results in the same survival as primarily resected gallbladder cancers H Hoshi, JM Foster, Q Chu, B Kuvshinoff, A Rajput, H Nava, JF Gibbs Department of Surgery, Roswell Park Cancer Institute, State University of New York at Buffalo, Elm & Carlton Streets, Buffalo, NY

    H. Hoshi, J. M. Foster, Q. Chu, B. Kuvshinoff, A. Rajput in Annals of Surgical Oncology (2004)